References
Blum MR, Lao SHT, Good SS, de Miranda P. Pharmacokinetics and bioavailability of zidovudine in humans. American Journal of Medicine (Suppl. 2A): 189–194, 1988
Collins JM, Unadkat JD. Clinical pharmacokinetics of zidovudine. Clinical Pharmacokinetics 17: 1–9, 1989
Desmond PV, Patwardhan R, Parker R, Schenker S, Speed KV. Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Science 26: 1261–1268, 1980
Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. New England Journal of Medicine 317: 185–191, 1987
Good SS, Durack DT, de Miranda P. Biotransformation in various species and in humans of 3′-azido-3′-deoxythymidine, a potential agent for treatment of AIDS. Federation Proceedings 45: 444, 1986
Henry DA, Sharp G, Chaplain S, Cartwright S, Kitchingman G, et al. The 14C-aminopyrine breath test: a comparison of different forms of analysis. British Journal of Clinical Pharmacology 8: 539–545, 1979
Henry DA, Macdonald IA, Kitchingman G, Bell GD, Langman MJS. Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. British Medical Journal 281: 775–777, 1980
Hepner GW, Vesell ES, Lipton A, Harvey HA, Wilkinson GR, et al. Disposition of aminopyrine, antipyrine, diazepam and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination. Journal of Laboratory and Clinical Medicine 80: 440–456, 1977
Millar A. Aids and the lung. British Medical Journal 249: 1334–1337, 1987
Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with aids and aids related complex. New England Journal of Medicine 317: 192–197, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barry, M.G., Mulcahy, F. & Feely, J. Zidovudine and Hepatic Oxidative Drug Metabolism. Drug Invest. 2, 200–202 (1990). https://doi.org/10.1007/BF03259196
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259196